Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00307515 · ClinicalTrials.gov registry record · Phase 3
Evaluation of Fibrin Sealant 2 in Retroperitoneal or Intra-Abdominal Surgery
A Phase 3 study of Blood Loss, Surgical, sponsored by Ethicon.
- Completed
- Registry status
- Phase 3
- Development phase
- 135
- Enrollment target
- 16
- Study locations
NCT00307515 is a Phase 3 study of Blood Loss, Surgical that has completed, run by Ethicon. The registered enrollment target is 135 participants, above the 114-participant average among 6 other Blood Loss, Surgical trials with a reported enrollment target (18% higher). The trial reports 16 study locations across 11 states.
The verdict
NCT00307515, a Phase 3 study of Blood Loss, Surgical, has completed, sponsored by Ethicon.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 135 participants
- Enrollment target
- 16
- Study locations
Study Summary
A comparison of fibrin sealant 2 versus Surgicel® as an addition to standard surgical practice in stopping mild to moderate soft tissue bleeding during retroperitoneal or intra-abdominal surgery.
Conditions Studied
Interventions
- DRUG Fibrin Sealant 2 (FS2)
- DEVICE Oxidized Regenerated Cellulose (Surgicel)
Study Locations (16)
Pennsylvania
- Lehigh Valley Hospital - Allentown
- Children's Hospital of Pittsburgh - Pittsburgh
- Lankenau Hospital - Wynnewood
Florida
- Jacksonville Center for Clinical Research - Jacksonville
- Miami Research Associates - Miami
New York
- Mt. Sinai Hospital - New York
- GYN Oncology Associates - Syracuse
Texas
- MD Anderson Cancer Center - Houston
- The Methodist Hospital - Houston
California
- Children's Hospital of Los Angeles - Los Angeles
Georgia
- Medical College of Georgia - Augusta
Iowa
- The Iowa Clinic - Des Moines
Maryland
- St. Agnes Healthcare, Inc. - Baltimore
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 135 participants |
| Start Date | 2006-02 |
| Est. Completion | 2006-12 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00307515
The ClinicalTrials.gov registry entry for NCT00307515 describes a study currently listed as completed, categorized as Phase 3. The registered enrollment target is 135 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 114-participant average among 6 other Blood Loss, Surgical trials with a reported enrollment target (18% higher). The listed sponsor is Ethicon, which has 38 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Blood Loss, Surgical appearing as the primary indexed condition, and to 2 interventions - of which Fibrin Sealant 2 (FS2) is the first listed.
NCT00307515 reports 16 study locations spanning 11 distinct geographic areas - top geographies include Pennsylvania, Florida, New York.
Frequently Asked Questions
What is clinical trial NCT00307515 about?
NCT00307515 is a clinical study titled "Evaluation of Fibrin Sealant 2 in Retroperitoneal or Intra-Abdominal Surgery". A comparison of fibrin sealant 2 versus Surgicel® as an addition to standard surgical practice in stopping mild to moderate soft tissue bleeding during retroperitoneal or intra-abdominal surgery.
What is the current status of trial NCT00307515?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 135 participants. The study started on 2006-02. Estimated completion is 2006-12.
What conditions does trial NCT00307515 study?
This clinical trial studies the following conditions: Blood Loss, Surgical.
What interventions are being tested in trial NCT00307515?
The interventions under investigation include: Fibrin Sealant 2 (FS2) (DRUG), Oxidized Regenerated Cellulose (Surgicel) (DEVICE).
Who is sponsoring clinical trial NCT00307515?
This trial is sponsored by Ethicon, which has 38 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00307515 being conducted?
This trial has 16 study locations across California, Florida, Georgia, Iowa, Maryland. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Blood Loss, Surgical
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Tranexamic Acid in Adult Spinal Deformity Surgery
RECRUITING · Phase 3
-
Role of TXA in Patients Undergoing Breast Free Flap Reconstruction
RECRUITING · Phase 4
-
Prophylactic Intravenous Calcium Gluconate to Decrease Blood Loss at Time of Cesarean Delivery in Pregnant Patients at High Risk for Uterine Atony
RECRUITING · Phase 2
-
PCC vs. FFP for Post Cardiopulmonary Bypass Coagulopathy and Bleeding
COMPLETED · Phase 4
-
Oral and Intravenous Tranexamic Acid in Lumbar Spine Surgery
COMPLETED · Phase 4
-
Vasopressin Administration During Laparoscopic Myomectomy: a Randomized Controlled Trial
COMPLETED · Phase 4
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.